Live feed07:00:00·39dPRReleasevia QuantisnowRadiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain MetastasesByQuantisnow·Wall Street's wire, on your screen.RADX· Radiopharm Theranostics LimitedHealth Care
